0001654954-21-004809.txt : 20210601 0001654954-21-004809.hdr.sgml : 20210601 20210429161122 ACCESSION NUMBER: 0001654954-21-004809 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDRA Life Sciences Inc. CENTRAL INDEX KEY: 0001681682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 260579295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 BUSINESS PHONE: 734-335-0468 MAIL ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 FORMER COMPANY: FORMER CONFORMED NAME: Endra Inc. DATE OF NAME CHANGE: 20160805 CORRESP 1 filename1.htm ndra_corresp
 
 
ENDRA Life Sciences Inc.
 
3600 Green Court, Suite 350
 
Ann Arbor, MI 48105
 
April 29, 2021
 
Securities and Exchange Commission
100 F Street, N.E. 
Washington, D.C. 20549
 
Attention: Irene Paik
 
Re: 
ENDRA Life Sciences Inc.
Registration Statement on Form S-3
Filed March 25, 2021
File No. 333-254711
 
Ladies and Gentlemen:
 
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant ENDRA Life Sciences Inc. hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:15 p.m., Eastern Time, on Monday, May 3, 2021, or as soon thereafter as is practicable.
 
Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted.
 
Sincerely,
 
/s/ Francois Michelon
 
Francois Michelon
Chief Executive Officer and Director